Automated Pharmacy Edits Clear Two-Thirds Of COX-2 Rxs Approved By MVP
Automated point-of-service pharmacy edits were responsible for authorizing 64% of the COX-2 inhibitor scripts approved by the health management organization MVP in the fourth quarter of 1999.
You may also be interested in...
Pipeline pharmaceuticals will be responsible for 40% of the annual increase in pharmaceutical expenditures over the next five years, according to an insurance industry-sponsored study.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011